Does RALTEGRAVIR Cause Hyperbilirubinaemia? 33 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 33 reports of Hyperbilirubinaemia have been filed in association with RALTEGRAVIR (ISENTRESS). This represents 0.4% of all adverse event reports for RALTEGRAVIR.
33
Reports of Hyperbilirubinaemia with RALTEGRAVIR
0.4%
of all RALTEGRAVIR reports
2
Deaths
22
Hospitalizations
How Dangerous Is Hyperbilirubinaemia From RALTEGRAVIR?
Of the 33 reports, 2 (6.1%) resulted in death, 22 (66.7%) required hospitalization, and 3 (9.1%) were considered life-threatening.
Is Hyperbilirubinaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RALTEGRAVIR. However, 33 reports have been filed with the FAERS database.
What Other Side Effects Does RALTEGRAVIR Cause?
Foetal exposure during pregnancy (1,033)
Maternal exposure during pregnancy (726)
Exposure during pregnancy (700)
Drug interaction (552)
Virologic failure (517)
Depression (482)
Death (431)
Pathogen resistance (425)
Drug resistance (388)
No adverse event (339)
What Other Drugs Cause Hyperbilirubinaemia?
METHOTREXATE (603)
RIBAVIRIN (560)
VINCRISTINE (479)
CYTARABINE (397)
PEGASPARGASE (349)
ACETAMINOPHEN (330)
CYCLOPHOSPHAMIDE (330)
DEXAMETHASONE (315)
CAPECITABINE (279)
SOFOSBUVIR (260)
Which RALTEGRAVIR Alternatives Have Lower Hyperbilirubinaemia Risk?
RALTEGRAVIR vs RALTITREXED
RALTEGRAVIR vs RAMELTEON
RALTEGRAVIR vs RAMIPRIL
RALTEGRAVIR vs RAMUCIRUMAB
RALTEGRAVIR vs RANEXA